Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Find
Thursday, January 23, 2020
Posted by: Natalia Gromov
Toumazis I, Tsai EB, Erdogan SA, Han SS, Wan W, Leung A, Plevritis SK.
Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Findings.
JNCI Cancer Spectr. 2019 May 23;3(3):pkz035. doi: 10.1093/jncics/pkz035. eCollection 2019 Sep.
Numerous health policy organizations recommend lung cancer screening, but no consensus exists on the optimal policy. Moreover, the impact of the Lung CT screening reporting and data system guidelines to manage small pulmonary nodules of unknown significance (a.k.a. indeterminate nodules) on the cost-effectiveness of lung cancer screening is not well established.
The disutility associated with indeterminate findings impacts the cost-effectiveness of lung cancer screening. Efforts to quantify and better understand the impact of indeterminate findings on the effectiveness and cost-effectiveness of lung cancer screening are warranted.
|
|
Email to a Friend